Literature DB >> 3872459

Alternative RNA processing events in human calcitonin/calcitonin gene-related peptide gene expression.

V Jonas, C R Lin, E Kawashima, D Semon, L W Swanson, J J Mermod, R M Evans, M G Rosenfeld.   

Abstract

Two mRNAs generated as a consequence of alternative RNA processing events in expression of the human calcitonin gene encode the protein precursors of either calcitonin or calcitonin gene-related peptide (CGRP). Both calcitonin and CGRP RNAs and their encoded peptide products are expressed in the human pituitary and in medullary thyroid tumors. On the basis of sequence comparison, it is suggested that both the calcitonin and CGRP exons arose from a common primordial sequence, suggesting that duplication and rearrangement events are responsible for the generation of this complex transcription unit.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872459      PMCID: PMC397471          DOI: 10.1073/pnas.82.7.1994

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Transcription terminates in yeast distal to a control sequence.

Authors:  S Henikoff; J D Kelly; E H Cohen
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

2.  Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary.

Authors:  L J Deftos; D Burton; B D Catherwood; H G Bone; J G Parthemore; R Guillemin; W B Watkins; R Y Moore
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

3.  Calcitonin mRNA polymorphism: peptide switching associated with alternative RNA splicing events.

Authors:  M G Rosenfeld; C R Lin; S G Amara; L Stolarsky; B A Roos; E S Ong; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Absence of detectable calcitonin synthesis in the pituitary using cloned complementary deoxyribonucleic acid probes.

Authors:  J W Jacobs; D Goltzman; J F Habener
Journal:  Endocrinology       Date:  1982-12       Impact factor: 4.736

5.  Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products.

Authors:  S G Amara; V Jonas; M G Rosenfeld; E S Ong; R M Evans
Journal:  Nature       Date:  1982-07-15       Impact factor: 49.962

6.  Ability of calcitonins to alter food and water consumption in the rat.

Authors:  M J Twery; J F Obie; C W Cooper
Journal:  Peptides       Date:  1982 Sep-Oct       Impact factor: 3.750

7.  Alternative RNA splicing of the murine alpha A-crystallin gene: protein-coding information within an intron.

Authors:  C R King; J Piatigorsky
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

8.  Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing.

Authors:  M G Rosenfeld; J J Mermod; S G Amara; L W Swanson; P E Sawchenko; J Rivier; W W Vale; R M Evans
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

9.  Drosophila has one myosin heavy-chain gene with three developmentally regulated transcripts.

Authors:  C E Rozek; N Davidson
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

10.  Organization of the rat gamma-fibrinogen gene: alternative mRNA splice patterns produce the gamma A and gamma B (gamma ') chains of fibrinogen.

Authors:  G R Crabtree; J A Kant
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

View more
  32 in total

1.  Calcitonin gene related peptide.

Authors:  D J O'Halloran; S R Bloom
Journal:  BMJ       Date:  1991-03-30

2.  Hybridohistochemical demonstration of alternative splicing of the CALC-I gene.

Authors:  M Denijn; R A De Weger; C J Lips; J A Van Unnik; W Den Otter
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

3.  Human calcitonin gene regulation by helix-loop-helix recognition sequences.

Authors:  D W Ball; D Compton; B D Nelkin; S B Baylin; A de Bustros
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

Review 4.  Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.

Authors:  Vivian Hook; Lydiane Funkelstein; Douglas Lu; Steven Bark; Jill Wegrzyn; Shin-Rong Hwang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

5.  Differential utilization of calcitonin gene regulatory DNA sequences in cultured lines of medullary thyroid carcinoma and small-cell lung carcinoma.

Authors:  A de Bustros; R Y Lee; D Compton; T Y Tsong; S B Baylin; B D Nelkin
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

6.  Model for tissue specific Calcitonin/CGRP-I RNA processing from in vitro experiments.

Authors:  R A Bovenberg; G J Adema; H S Jansz; P D Baas
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

7.  Human alpha-calcitonin gene-related peptide (CGRP) is a potent vasodilator in human mesenteric vasculature.

Authors:  I Marshall; S J Al-Kazwini; J J Holman; R K Craig
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

8.  Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma.

Authors:  J M Conlon; L Grimelius; L Thim
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

9.  Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties.

Authors:  Daisuke Ito; John R Walker; Charlie S Thompson; Isabella Moroz; William Lin; Margaret L Veselits; Antoine M Hakim; Allen A Fienberg; Gopal Thinakaran
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Locus Reference Genomic sequences: an improved basis for describing human DNA variants.

Authors:  Raymond Dalgleish; Paul Flicek; Fiona Cunningham; Alex Astashyn; Raymond E Tully; Glenn Proctor; Yuan Chen; William M McLaren; Pontus Larsson; Brendan W Vaughan; Christophe Béroud; Glen Dobson; Heikki Lehväslaiho; Peter Em Taschner; Johan T den Dunnen; Andrew Devereau; Ewan Birney; Anthony J Brookes; Donna R Maglott
Journal:  Genome Med       Date:  2010-04-15       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.